Article info

Download PDFPDF
Systematic review and meta-analysis
Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events

Authors

  1. Correspondence to Swapnil N Rajpathak
    US Outcomes Research, Merck, 351 N Sumneytown Pike, UG2MW-05, North Wales, PA 19454, USA; swapnil.rajpathak{at}merck.com
View Full Text

Citation

Rajpathak SN
Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events

Publication history

  • First published September 26, 2011.
Online issue publication 
March 24, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.